Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04QIE
|
|||
| Former ID |
DIB006814
|
|||
| Drug Name |
Pemafibrate
|
|||
| Synonyms |
K-877
Click to Show/Hide
|
|||
| Indication | Hyperlipidemia [ICD-11: 5C80.Z] | Approved | [1] | |
| Cardiovascular disease [ICD-11: BA00-BE2Z; ICD-10: I00-I99, E78; ICD-9: 390-459] | Phase 3 | [2] | ||
| Lipid metabolism disorder [ICD-11: 5C52.Z] | Phase 3 | [3] | ||
| Company |
Kowa Co Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H30N2O6
|
|||
| Canonical SMILES |
CCC(C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3
|
|||
| InChI |
1S/C28H30N2O6/c1-3-25(27(31)32)35-23-9-6-8-20(18-23)19-30(28-29-24-10-4-5-11-26(24)36-28)16-7-17-34-22-14-12-21(33-2)13-15-22/h4-6,8-15,18,25H,3,7,16-17,19H2,1-2H3,(H,31,32)/t25-/m1/s1
|
|||
| InChIKey |
ZHKNLJLMDFQVHJ-RUZDIDTESA-N
|
|||
| CAS Number |
CAS 848259-27-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Pemafibrate: First Global Approval. Drugs. 2017 Oct;77(16):1805-1810. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032781) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.